Radicut (edaravone) vs Radicava ORS (edaravone)

Radicut (edaravone) is an intravenous medication approved for the treatment of amyotrophic lateral sclerosis (ALS), which is administered in a hospital or clinic setting, requiring patients to adhere to a schedule for infusion. Radicava ORS (also edaravone), on the other hand, is an oral suspension formulation that offers the convenience of at-home administration, potentially improving adherence and quality of life for patients. When deciding between the two, patients should consider factors such as their ability to travel to infusion centers, their preference for administration route, and any specific recommendations from their healthcare provider based on their individual health status and treatment plan.

Difference between Radicut and Radicava ORS

Metric	Radicut (edaravone)	Radicava ORS (edaravone)
Generic name	Edaravone	Edaravone
Indications	Amyotrophic lateral sclerosis (ALS)	Amyotrophic lateral sclerosis (ALS)
Mechanism of action	Free radical scavenger	Free radical scavenger
Brand names	Radicut, Radicava	Radicava ORS
Administrative route	Intravenous infusion	Oral suspension
Side effects	Contusions, gait disturbances, headache, skin inflammation, eczema	Constipation, contusions, walking disturbances, headache
Contraindications	Hypersensitivity to edaravone or any of the excipients	Hypersensitivity to edaravone or any of the excipients
Drug class	Neuroprotective agent	Neuroprotective agent
Manufacturer	Mitsubishi Tanabe Pharma	Mitsubishi Tanabe Pharma

Efficacy

Efficacy of Radicut (Edaravone) in ALS Treatment

Radicut, also known as edaravone, is a medication that has been approved for the treatment of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. The efficacy of Radicut in the treatment of ALS is based on its antioxidant properties, which are believed to help neutralize free radicals, potentially slowing the oxidative stress that contributes to the neuronal damage seen in ALS patients.

Clinical Trials and Approval

The approval of Radicut for ALS was primarily based on the results of a pivotal phase 3 clinical trial conducted in Japan. This trial demonstrated that edaravone could slow the decline in physical function in ALS patients, as measured by the ALS Functional Rating Scale-Revised (ALSFRS-R), a standardized instrument for assessing the progression of disability in ALS. The study found that patients treated with edaravone experienced a smaller decline in their functional score compared to those who received a placebo.

Radicava ORS (Edaravone) and Its Efficacy

Radicava ORS is an oral suspension formulation of edaravone that has been developed to provide a more convenient route of administration compared to the intravenous infusion of Radicut. While Radicava ORS is designed to deliver the same active ingredient, edaravone, its efficacy in ALS treatment is expected to mirror that of the intravenous formulation, offering a similar potential benefit in slowing down the functional decline associated with the disease.

Considerations and Ongoing Research

It is important to note that while Radicut and Radicava ORS can slow the progression of ALS, they are not a cure for the disease. The efficacy varies among individuals, and not all patients may respond to the treatment. Ongoing research continues to investigate the long-term benefits and potential of edaravone in different subpopulations of ALS patients, as well as its effects when used in combination with other therapies. Health care providers consider the overall health status of the patient and potential side effects when determining the suitability of edaravone for ALS treatment.

Regulatory Agency Approvals

Radicut

Food and Drug Administration (FDA), USA
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Radicava ORS

Food and Drug Administration (FDA), USA
Health Canada

Access Radicut or Radicava ORS today

If Radicut or Radicava ORS are not approved or available in your country (e.g. due to supply issues), you can access them via Everyone.org.

Buy Radicut

Buy Radicava ORS

How it works

Make an enquiry

Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.

Breeze through the paperwork

We'll guide you through the required documents for importing unapproved medicine, ensuring you have all the necessary information.

Get a personalized quote

We’ll prepare a quote for you, including medicine costs and any shipping, administrative, or import fees that may apply.

Receive your medicine

Accept the quote and we’ll handle the rest - sourcing and safely delivering your medicine.

Some text on this page has been automatically generated. Speak to your physician before you start a new treatment or medication.

Let's talk

If you have any questions, call us or send us a message through WhatsApp or email: